Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Arnoldo, Luca ^a   Migliavacca, Roberta ^b   Regattin, Laura ^c   Raglio, Annibale ^d   Pagani, Laura ^b   Nucleo, Elisabetta ^b   Spalla, Melissa ^b   Vailati, Francesca ^d   Agodi, Antonella ^e   Mosca, Adriana ^f   Zotti, Carla ^g   Tardivo, Stefano ^h   Bianco, Ines ⁱ   Rulli, Adele ⁱ   Gualdi, Paola ^j   Panetta, Pietro ^k   Pasini, Carlo ^l   Pedroni, Mino ^l   Brusaferro, Silvio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Azienda per i Servizi Sanitari 3 Alto Friuli   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF VERONA   (Italy)

ⁱ Azienda Sanitaria Locale 2 Lanciano Vasto Chieti   (Italy)

^j Azienda Provinciale Per I Servizi Sanitari Della Provincia Autonoma di Trento   (Italy)

^k Ambulatorio di Dermatologia   (Italy)

^l Azienda Ospedaliera di Desenzano del Garda   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CARBAPENEM; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA GENE; BLACTX M GENE; BLADDER CATHETERIZATION; BLATEM GENE; CITROBACTER KOSERI; COMORBIDITY; CONTROLLED STUDY; DECUBITUS; DISEASE PREDISPOSITION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; ETHNIC GROUP; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENE SEQUENCE; GENETIC RESISTANCE; HEALTH CARE FACILITY; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; ITALIAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; SPECIES IDENTIFICATION; URINARY CATHETER;

AGED, 80 AND OVER; BETA-LACTAMASES; CARRIER STATE; CROSS-SECTIONAL STUDIES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; LONG-TERM CARE; MALE; PREVALENCE; REGRESSION ANALYSIS; URINARY CATHETERIZATION; URINE;

EID: 84875368822     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-124     Document Type: Article

References (30)

1. Nicolle LE. Preventing infections in non hospital settings: long term care. Emerg Infect Dis 2001, 7(2):205-207. 10.3201/eid0702.010210, 2631702, 11294707.
2. Mc Geer A, Campbell B, Emori TG, Hierholzer WJ, Jackson MM, Nicolle LE. Definitions of infection for surveillance in long term care facilities. Am J Infect Control 1991, 19(1):1-7. 10.1016/0196-6553(91)90154-5, 1902352.
3. Loeb MB, Craven S, McGeer AJ, Simor AE, Bradley SF, Low DE. Risk factors for resistance to antimicrobial agents among nursing home resident. Am J Epidemiol 2003, 157(1):40-47. 10.1093/aje/kwf173, 12505889.
4. Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruymi R. Epidemiology of multidrug resistant bacteria in patients with long hospital stays. Infect Contr Hosp Epidemiol. 2007, 28(11):1255-1260.
5. Nicolle LE, Strusbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 1996, 9(1):1-17. 172878, 8665472.
6. Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med 2006, 119(1):20-28. Jun.
7. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended spectrum beta lactamases among Escherichia coli isolates collected in a swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008, 46(2):707-712. 10.1128/JCM.01943-07, 2238137, 18094139.
8. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R. Clinical and molecular epidemiology of extended spectrum beta lactamases producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006, 42(1):37-45. 10.1086/498519, 16323089.
9. Nicolas-Chanoine ME, Jarlier V, . la Collegiale de bacteriologie virologie Hygiene Hospitaliere de l'Assistance Publique. Hopitaux De Paris France. Extended spectrum beta lactamases in long term care facilities. Clin Microbiol Infect 2008, 14(Suppl 1):111-116. la Collegiale de bacteriologie virologie Hygiene Hospitaliere de l'Assistance Publique. Hopitaux De Paris France..
10. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA. Risk factors for acquisition of extended spectrum beta lactamase-producing Escherichia coli among hospitalised patient. Clin Microbiol Infect 2006, 12(3):279-284. 10.1111/j.1469-0691.2005.01358.x, 16451416.
11. Lee YS, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended spectrum beta lactamases producing Escherichia coli and Klebsiella species on clincal outcomes and hospitals costs: a matched cohort study. Infect Control Hosp Epidemiol 2006, 27(11):1226-1232. 10.1086/507962, 17080381.
12. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281(6):517-523. 10.1001/jama.281.6.517, 10022107.
13. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F. Bloodstream infections causes by extended spectrum beta lactamase producing Klebsiella pneumonie: risk factors. molecular epidemiology. and clincial outcome. Antimicrob Agents Chemother 2006, 50(2):498-504. 10.1128/AAC.50.2.498-504.2006, 1366869, 16436702.
14. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G. CTX-M-type extended spectrum beta lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006, 50(8):2700-2706. 10.1128/AAC.00068-06, 1538672, 16870761.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement M100-S18 2008, Wayne PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute.
16. Nuesch-Inderbinen MT, Hachler H, Kayser FH. Detection of genes coding for extended spectrum SHV beta lactamases in clinical isolates by a molecular genetic method and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996, 15(5):398-402. 10.1007/BF01690097, 8793399.
17. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A. Detection of CTX-M-Type β-lactamase gnes in fecal Escherichia coli isolates from healthy children in Bolivia and Perù. Antimicrob Agents Chemother 2004, 48(12):4556-4561. 10.1128/AAC.48.12.4556-4561.2004, 529195, 15561825.
18. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Amicosante G, Rossolini GM. Dissemination of CTX-M-Type extended spectrum beta lactamase genes to unusual hosts. J Clin Microbiol 2005, 43(8):4183-4185. 10.1128/JCM.43.8.4183-4185.2005, 1233897, 16081971.
19. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z. Dissemination of CTX-M-type β-lactamase among clinical isolates of enterobacteriaceae in Paris France. Antimicrob Agents Chemother 2004, 48(4):1249-1255. 10.1128/AAC.48.4.1249-1255.2004, 375249, 15047527.
20. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the national committee for clinical laboratory standards extended-spectrum β-lactamase detection methods. J Clin Microbiol 2001, 39(8):2864-2872. 10.1128/JCM.39.8.2864-2872.2001, 88252, 11474005.
21. D'Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F. CMY-16 a novel acquired AmpC-type beta lactamase of the CMY/LAT lineage in multifocal monophylic isolates of Proteus mirabilis from northern Italy. Antimicrob Agents Chemother 2006, 50:618-624. 10.1128/AAC.50.2.618-624.2006, 1366893, 16436718.
22. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediation AmpC beta lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40(6):2153-2162. 10.1128/JCM.40.6.2153-2162.2002, 130804, 12037080.
23. Brusaferro S, Regattin L, Silvestro A, Vidotto L. Incidence of hospital-acquired infections in Italian long-term-care facilities: a prospective six-month surveillance. J Hosp Infect 2006, 63(2):211-215. 10.1016/j.jhin.2006.01.012, 16600433.
24. Pagani L, Migliavacca R, Pallecchi L, Matti C, Giacobone E, Amicosante G. Emerging estende spectrum beta lactamases in Proteus mirabilis. J Clin Microbiol 2002, 40(4):1549-1552. 10.1128/JCM.40.4.1549-1552.2002, 140357, 11923394.
25. Yoo JS, Byeon J, Yang J, Yoo JI, Chung GT, Lee YS. High prevalence of extended spectrum beta lactamases and plasmid-mediated AmpC β-lactamases in wnterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 2010, 67(3):261-265. 10.1016/j.diagmicrobio.2010.02.012, 20462727.
26. March A, Aschbacher R, Dhanji H, Livermore DM, Böttcher A, Sleghel F. Colonization of residents and staff of a long term care facility and adjacent acute-care hospital geriatric unit by multi-resistant bacteria. Clin Microbiol Infect 2010, 16(7):934-944.
27. Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W. Identification of CTX-M beta lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis 2010, 66(4):402-406. 10.1016/j.diagmicrobio.2009.11.012, 20226330.
28. Carattoli A, García-Fernández A, Varesi P, Fortini D, Gerardi S, Penni A. Molecular epidemiology of Escherichia coli producing extended-spectrum beta lactamases isolated in Rome, Italy. Clin Microbiol. 2008, 46(1):103-108.
29. Luzzaro F, Brigante G, D'Andrea MM, Pini B, Giani T, Mantengoli E. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta lactamase: epidemiology and clinical management. Int J Antimicrob Agents 2009, 33(4):328-333. 10.1016/j.ijantimicag.2008.09.007, 19095415.
30. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008, 62(1):1-9. 10.1093/jac/dkn175, 2574594,2574594, 18441341.